While the mainstay of T1D treatment is intensive insulin treatment either with multiple daily injections or continuous subcutaneous insulin infusion, efforts are underway to identify treatments that may preserve β-cell mass and function [8]. Here, INS is linked to type 1 diabetes mellitus.